Project Mercury Impact: A toolkit for new facioscapulohumeral muscular dystrophy trial sites
Facioscapulohumeral muscular dystrophy (FSHD) is at a turning point, with multiple disease-modifying therapies in development. To ensure global access, clinical trial readiness across diverse regions
January 14, 2026